CTIS.eu › Cities › Poland › Kielce
Kielce
Poland
169 total trials
72 recruiting
2023-507906-15-00
5
2019-01-30
Relapsing multiple sclerosis (RMS)
2024-515499-12-00
5
2017-10-02
Acute lymphoblastic leukemia
2023-507705-34-00
5
2025-08-29
Moderate to Severe Active Ulcerative Colitis
2024-513104-34-00
4
2024-11-25
Major Depressive Disorder
2024-511583-82-00
5
2024-10-08
Plaque psoriasis
2024-511363-28-00
5
2024-09-24
hidradenitis suppurativa (HS)
2023-504942-75-01
5
2024-08-22
Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis with or witho
2023-506570-12-01
4
2024-06-13
Cognitive disorder
2023-505712-37-00
10
2024-06-06
The participants must have a histologically confirmed diagnosis of res
2023-506655-19-00
4
2024-05-16
Ulcerative Colitis (UC)
2023-504812-13-00
11
2024-05-06
Arterial hypertension
2022-502457-34-00
4
2024-03-13
Triple-Negative Breast Cancer (TNBC)
2023-508013-16-00
5
2024-02-26
Birch pollen induced allergic rhinitis or rhinoconjunctivitis
2023-505543-39-00
5
2024-02-12
Chronic Obstructive Pulmonary Disease (COPD)
2023-505910-10-00
4
2024-01-23
Relapsed or Refractory High-Risk Myelodysplastic Syndrome
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
2023-503657-35-00
5
2023-10-10
Obesity
2022-502552-31-00
4
2023-10-03
Relapsing Forms of Multiple Sclerosis
2024-514764-72-00
5
2023-09-27
Chronic Urticaria
2022-502196-31-00
10
2023-08-21
Advanced or Recurrent Endometrial Cancer
2022-501417-31-01
5
2023-08-01
melanoma
2022-500536-11-01
5
2023-06-08
Moderately to severely active ulcerative colitis
2022-502575-30-00
5
2023-05-23
Atopic Dermatitis
2023-507665-25-00
5
2023-04-25
Severe Eosinophilic asthma
Showing 121–144 of 169 trials